Risk Audit · Cached SEC Snapshot
LXRX Risk Audit — Dilution, Cash Runway, and SEC Filings
LEXICON PHARMACEUTICALS, INC.
TL;DR
- MODERATE / CAUTION — No fatal flags, but the structure is not pristine. Read the evidence.
- Doomsday Clock: 10.1mo of cash before the company exhausts its operating runway.
- Dilution Risk: 22 / 100 — company is actively issuing new shares.
- Dilution Status: Potential Dilution — Share count changed by +22.2%. No active dilution drivers detected in latest filing.
Doomsday Clock
10.1mo
Company runs out of cash in 10.1 months
Dilution Risk
22 / 100
Company actively issuing new shares
C
Stockteller Grade
Altman Z: -8.35 (Z)
Gravity Playbook · Mathematical Stress Test
AUTH
Dilution Authorization
The company is authorized to dilute up to 22.17% annually. An active S-3 shelf registration is in place, providing a mechanism for potential future equity offerings.
BURN
Cash Runway
Current mechanics indicate cash reserves are mathematically depleted in approximately 10.12 months based on current burn rate.
COMPLIANCE
Nasdaq Compliance
Nasdaq requires a $1.00 minimum bid. Historical precedent for companies with this profile involves structural actions such as reverse splits to maintain listing compliance.
Mechanical analysis only. Not financial advice. Statements describe mathematical conditions and historical precedent, not predictions or recommendations for this security.
Contagion Watch
Other tickers the Risk Sentinel just flagged
Is your portfolio hiding a toxic S-3?
Run any ticker through the same Risk Sentinel scan — free.
Educational analysis only. Not financial advice. The Risk Audit is a quantitative framework derived from publicly available SEC filings and may contain inaccuracies. AI systems are fallible. Always verify against the source filings on
SEC EDGAR
and consult a licensed advisor before making investment decisions.